CJC-1295 With DAC is a modified growth hormone-releasing hormone (GHRH) analog engineered with a Drug Affinity Complex (DAC) for extended half-life in laboratory research. This 30-amino acid synthetic peptide is studied in controlled in-vitro settings for its potential involvement in growth hormone axis signaling and pituitary function research.

Supplied as lyophilized powder, this product is intended exclusively for controlled in-vitro laboratory research by qualified professionals.

Chemical Information:

• Chemical Name: GRF 1-29 (modified) with Drug Affinity Complex
• Amino Acid Count: 30 amino acids (CJC-1295) + DAC extension
• Molecular Formula: Complex peptide construct with modified terminus
• Molecular Weight: ~3647.28 g/mol (with DAC modification)
• Compound Class: Synthetic GHRH analog; pituitary research peptide

Research Applications:

• In-vitro evaluation of GHRH receptor signaling in pituitary cell models
• Investigation of growth hormone axis pathway modulation in laboratory assays
• Study of extended-acting peptide mechanism in controlled environments
• Examination of DAC modification impact on peptide-receptor interactions

Storage and Handling:

• Store at -20°C for extended preservation or 2-8°C for short-term use
• Protect from light; maintain tightly sealed containers
• Use sterile, pyrogen-free water for reconstitution
• Handle with appropriate laboratory safety and aseptic techniques

Product Specifications:

• Purity: ≥98% (HPLC)
• Appearance: White lyophilized powder
• Form: Lyophilized powder
• Quantity: 2mg per vial

Compliance Notice:
FOR RESEARCH USE ONLY — Not for human or veterinary consumption. This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the Food and Drug Administration for any purpose.